This prospective multicentre phase II study evaluated targeted microwave ablation (TMA) using OBT Fusion in men with localised intermediate-risk prostate cancer, showing 81% of ... Read the study
Chiu et al. 2024 Dec
Targeted microwave ablation (TMA) is a novel focal therapy modality for prostate cancer (PC). TMA-HK is the first phase 2 tri... Read the study
Oderda et al. 2024 Nov
Targeted microwave ablation (TMA) is a novel modality of focal therapy to treat localized prostate cancer (PCa). We evaluat... Read the study
Peltier et al., May 2024
To assess histopathological outcomes, as well as feasibility and safety of targeted microwave ablation (TMA) via the Trin... Read the study
Oderda et al., Oct 2022
Focal therapy has emerged as an interesting option for localized low- to intermediate-risk prostate cancer (PCa). Targeted... Read the study
CHIU et al., Nature Prostate Cancer and Prostatic Disease , July 2022
To investigate the efficacy of transperineal targeted microwave ablation (TM... Read the study
Barry-Delongchamps et al, July 2021
To assess the feasibility, safety and precision of organ-based tracking (OBT)-fusion targeted focal microwave ... Read the study